Genome-Wide Linkage Survey for Genetic Loci that Influence the Development of Depressive Disorders in Families with Recurrent, Early-Onset, Major Depression

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 123 B, Issue 1, 2003, Pages 1-18

  Zubenko, George S ^a,b,f   Maher, Brion ^c   Hughes III, Hugh B ^a   Zubenko, Wendy N ^a   Stiffler, J Scott ^a   Kaplan, Barry B ^d   Marazita, Mary L ^a,c,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Carnegie Mellon University ^*  (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

CREB1; Depression; Depression spectrum; Genetic linkage; Genome wide scan; Sex specificity

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA;

ARTICLE; CLINICAL FEATURE; CREB1 GENE; DEPRESSION; DISEASE PREDISPOSITION; DNA SEQUENCE; FAMILY STUDY; FEMALE; GENE; GENETIC LINKAGE; GENOME; GENOME WIDE SCAN; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MOOD DISORDER; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SIBLING;

EID: 0142157161     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20073     Document Type: Article

References (71)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association.
2. Andreasen NC, Rice J, Endicott J, Reich T, Coryell W. 1986. The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry 43:421-429.
3. Angst J, Angst F, Stassen HH. 1999. Suicide risk in patients with major depressive disorder. J Clin Psychiatry 60:57-62.
4. Berrettini W. 2000. Susceptibility loci for bipolar disorder: Overlap with inherited vulnerability to schizophrenia. Biol Psychiatry 47:245-251.
5. Berrettini W. 2001. Molecular genetic studies of bipolar disorders. Bipolar Disorders 3:276-283.
6. Borman RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL, Carey J, Coleman RA, Baxter GS. 2002. 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol 135:1144-1151.
7. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. 1998. Comprehensive human genetic maps: Individual and sex-specific variation in recombination. Am J Hum Genet 63:861-869.
8. Chang L, Heitkamper MM. 2002. Gender differences in irritable bowel syndrome. Gastroentorology 123:1686-1701.
9. Dick DM, Nurnberger J Jr, Edenberg HJ, Goate A, Croew R, Rice R, Bucholz KK, Kramer J, Schuckit MA, Smith TL, Porjesz B, Begleiter H, Hesselbrock V, Foroud T. 2002. Suggestive linkage on chromosome 1 for a quantitative alcohol-related phenotype. Alcohol Clin Exp Res 26:1453-1460.
10. Duman RS, Vaidya VA. 1998. Molecular and cellular actions of chronic electroconvulsive seizures. J ECT 14:181-193.
11. Egeland JA, Gerhard DS, Pauls DL, Sussex JN, Kidd KK, Allen CR, Hostetter AM, Housman DE. 1987. Bipolar affective disorder linked to DNA makers on chromosome 11. Nature 325:783-787.
12. Endicott J, Andreasen N, Spitzer RL. 1975. Family history-research diagnostic criteria. New York: New York State Psychiatric Institute, Biometrics Research.
13. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, Markel P, Lee H, Harkavy Friedman J, Kaufmann C, Cloninger CR, Tsuang MT. 1998. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millenium Consortium. Am J Med Genet (Neuropsychiatr Genet) 81:290-295.
14. Garakani A, Win T, Subhdeep V, Gupta S, Kaplan D, Masand PS. 2003. Comorbidity of irritable bowel syndrome in psychiatric patients. Am J Ther 10:61-67.
15. Goddard KAB, Witte JS, Suarez BK, Catalona WJ, Olson JM. 2001. Model-free linkage analysis with covariates confirms linkage ofprostate cancer to chromosomes 1 and 4. Am J Hum Genet 68:1197-1206.
16. Hamilton SP, Fyer AJ, Dumer M, Heiman GA, Baisre de Leon A, Hodge SE, Knowles JA, Weissman MM. 2003. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA 100:2550-2555.
17. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, Leventhal BL, Cook EH Jr. 2002. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet (Neuropsychiatr Genet) 114:541-552.
18. Kalkoven E, Roelfsema JH, Teunissen H, den Boer A, Ariyurek Y, Zantema A, Bruening MH, Hennekam RCM, Peters DJM. 2003. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum Mol Genet 12:441-450.
19. Karayiorgou M, Gogos JA, Galke BL, Jeffery JA, Nestadt G, Wolyniec PS, Antonarakis SE, Kazazian HH, Housman DE, Driscoll DA, Pulver AE. 1996. Genotype and phenotype analysis at the 22q11 schizophrenia susceptibility locus. Cold Spring Harb Symp Quant Biol 61:835-843.
20. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE, Kazazian HH, Housman DE, Pulver AE. 1998. Identification of sequence variants and analysis of the role of the catechol-O-transferase gene in schizophrenia susceptibility. Biol Psychiatry 43:425-431.
21. Lander ES, Green P. 1987. Construction of multilocus genetic maps in humans. Proc Natl Acad Sci USA 84:2363-2367.
22. Lander E, Kruglyak L. 1995. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-246.
23. Lazennec G, Thomas JA, Katznellenbogen BS. 2001. Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators. J Steroid Biochem Mol Biol 77:193-203.
24. Levitas AS, Reid CS. 1998. Rubinstein-Taybi syndrome and psychiatric disorders. J Intellect Disabil Res 42:284-292.
25. Liu H, Abecasis GR, Heath SC, Knowles A, Demars S, Chen Y-J, J Roos L, Rapoport JL, Gogos JA, Karayiorgou M. 2002. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc Natl Acad Sci USA 99:16859-16864.
26. Long JC, Knowler WC, Hanson RL, Robin RW, Urbanek M, Moore E, Bennett PH, Goldman D. 1998. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet (Neuropsychiatr Genet) 81:216-221.
27. Maher BS, Marazita ML, Zubenko WN, Spiker DG, Giles DE, Kaplan BB, Zubenko GS. 2002a. Genetic segregation analysis of recurrent, early-onset major depression: Evidence for single major locus transmission. Am J Med Genet (Neuropsychiatr Genet) 114:214-221.
28. Maher BS, Zubenko WN, Kaplan BB, Marazita ML, Zubenko GS. 2002b. Genetic segregation analysis of alcohol and other substance use disorders in families with recurrent, early-onset major depression. Am J Drug Alcohol Abuse 28:711-731.
29. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Mol Cell Biol 2:599-609.
30. McEwen BS. 2001. Estrogens effects on the brain: Multiple sites and molecular mechanisms. J Appl Physiol 91:2785-2801.
31. Mukhopadhyay N, Almasy L, Schroeder M, Mulvihill WP, Weeks DE. 1999. Mega2, a data handling program for facilitating genetic linkage and association analyses. Am J Hum Genet 65:A436 (Version 2.3) available at http://watson.hgen.pitt.edu
32. Murata T, Kurokawa R, Krones A, Tatsumi K, Ishii M, Taki T, Masuno M, Ohashi H, Yanagisawa M, Resenfeld MG, Glass CK, Hayashi Y. 2001. Defect of acetyltransferase activity of the nuclear transcriptional factor CBP in Rubinstein-Taybi syndrome. Hum Mol Genet 10:1071-1076.
33. Murray CJ, Lopez AD. 1996. Evidence-based health policy: Lessons from the Global Burden of Disease Study. Science 274:740-743.
34. National Center for Biotechnology Information (NCBI). 2003. National Library of Medicine, National Institutes of Health. Entrez Human Map Viewer, Build 31. Chromosome 2 Map. URL: http://www.ncbi.nlm. nih.gov
35. Nestler EJ. 2001. Molecular neurobiology of addiction. Am J Addict 10:201-217.
36. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34:13-25.
37. Nurnberger JI Jr, Foroud T, Flury L, Su J, Meyer ET, Hu K, Crowe R, Edenberg H, Goate A, Bierut L, Reich T, Schuckit M, Reich W. 2001. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am J Psychiatry 158:718-724.
38. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identifying genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266.
39. Olson JM. 1999. A general conditional-logistic model for affected-relative-pair linkage studies. Am J Hum Genet 65:1760-1769.
40. Petrij F, Giles RH, Breuning M, Hennekam RCM. 2001. Rubinstein-Taybi syndrome. In: Scriver CR, Baudet A, Sly W, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill. pp 6167-6182.
41. Pruitt KD, Katz KS, Sicotte H, Maglott DR. 2000. Introducing RefSeq and LocusLink: Curated human genome resources at the NCBI. Trends Genet 16:44-47.
42. Pruitt KD, Maglott DR. 2001. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res 29:137-140.
43. Puig-Antich J, Orvaschel H, Tabrizi MA, Chambers W. 1980. The schedule for affective disorders and schizophrenia for school children-epidemiologic version (Kiddie-SADS-E). 3rd edition. New York State Psychiatric Institute and Yale University School of Medicine.
44. Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, Van Eerdewegh P, Foroud T, Hesselbrock V, Schuckit MA, Bucholz K, Porjesz B, Li TK, Conneally PM, Nurnberger JI Jr, Tischfield JA, Crowe RR, Cloninger CR, Wu W, Shears S, Carr K, Crose C, Willig C, Begleiter H, 1998. Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet (Neuropsychiatr Genet) 81:207-215.
45. Risch N. 1990. Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analyses of affected relative pairs. Am J Hum Genet 46:242-253.
46. Robins LN, Regier DA. 1991. Psychiatric disorders in America: The epidemiologic catchment area study. New York: The Free Press.
47. Rossby SP, Sulser F. 1997. Antidepressants: Events beyond the synapse. In: Skolnick P, editor. Antidepressants: New pharmacological strategies. Totowa, NJ: Humana Press. pp 195-212.
48. S.A.G.E. 2002. Statistical analysis for genetic epidemiology. Computer program package available from Cork, Ireland: Statistical Solutions Ltd.
49. Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K, Segman R, Borrman M, Dreikorn B, Lichtermann D, Rietschel M, Trixler M, Maier W, Wildenauer DB. 1998. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by non-parametric linkage analysis. Am J Med Genet (Neuropsychiatr Genet) 81:302-307.
50. Sklar P. 2002. Linkage analysis in psychiatric disorders: The emerging picture. Annu Rev Hum Genet 3:371-413.
51. Sobel E, Lange K. 1996. Descent graphs in pedigree analysis: Applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 58:1323-1337.
52. Spitzer RL, Endicott J. 1975. Schedule for affective disorders and schizophrenia-Lifetime version. New York: New York State Psychiatric Institute, Biometrics Research.
53. Spitzer RL, Endicott J, Robins E. 1978. Research diagnostic criteria. Rationale and reliability. Arch Gen Psychiatry 35:773-782.
54. Terwilliger JD, Speer M, Ott J. 1993. Chromosome-based method for rapid computer simulation in human genetic linkage analysis. Genet Epidemiol 10:217-224.
55. Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. 2002. Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. Proc Natl Acad Sci USA 99:7728-7733.
56. Tremblay A, Giguere V. 2001. Contribution of steroid receptor co-activator-1 and CREB binding protein in ligand-independent activity of estrogen receptor β, J Steroid Biochem Mol Biol 77:19-27.
57. U.S. Department of Health and Human Services. 1999. Mental health: A report of the Surgeon General-executive summary. Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health.
58. U.S. Public Health Service. 1999. The surgeon general's call to action to prevent suicide. Washington, DC.
59. Vaidya VA, Duman RS. 2001. Depression-emerging insights from neurobiology. Br Med Bull 57:61-79.
60. Valdes AM, McWeeney SK, Thomson G. 1999. Evidence for linkage and association to alcohol dependence on chromosome 19. Genet Epidemiol 17:S367-S372.
61. Weeber EJ, Sweatt JD. 2002. Molecular biology ofhuman cognition. Neuron 33:845-848.
62. Weissman MM, Merikangas KR, John K, Wickramaratne P, Prusoff BA, Kidd KK. 1986. Family genetic studies of psychiatric disorders. Arch Gen Psychiatry 43:1104-1116.
63. Winokur G. 1972. Depression spectrum disease: Description and family study. Comp Psychiatry 13:3-8.
64. Zubenko GS, Jones EW. 1981. Protein degradation, sporulation, and meiosis in proteinase deficient mutants ofyeast. Genetics 97:45-64.
65. Zubenko GS. 2000. Do susceptibility loci contribute to the expression of more than one mental disorder? A view from the genetics of Alzheimer's disease. Mol Psychiatry 5:131-136.
66. Zubenko GS, Zubenko WN, Spiker DG, Giles DE, Kaplan BB. 2001. The malignancy of recurrent, early-onset major depression: A family study. Am J Med Genet (Neuropsychiatr Genet) 105:690-699.
67. Zubenko GS, Hughes HB III, Maher BH, Stiffler JS, Zubenko WN, Marazita ML. 2002a. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet (Neuropsychiatr Genet) 114:980-987.
68. Zubenko GS, Hughes HB, Stiffler JS, Zubenko WN, Kaplan BB. 2002b. D2S2944 identifies a likely susceptibility locus for recurrent, early-onset, major depression in women. Mol Psychiatry 7(5):460-467.
69. Zubenko GS, Hughes HB III, Stiffler JS, Zubenko WN, Kaplan BB. 2002c. Genome survey for susceptibility loci for recurrent, early-onset major depression: Results at 10 cM resolution. Am J Med Genet (Neuropsychiatr Genet) 114:413-422.
70. Zubenko GS, Stiffier JS, Hughes HB, Fatigati MJ, Zubenko WN. 2002d. Genome survey for loci that influence successful aging: Sample characterization, method validation, andinitial results for they chromosome. Am J Geriatr Psychiatry 10:619-630.
71. Zubenko GS, Hughes HB, Stiffler JS, Brechbiel A, Zubenko WN, Maher B, Marizita ML. Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry (in press).